News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Smith & Nephew plc - Voting Rights and Capital
July 2, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
In conformity with the Transparency Directive, we notify the market that as at today's date: Smith & Nephew plc's issued share capital with voting rights consists of 927,825,661 ordinary shares of US20c each.
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Insights
Rewriting the rules of CMV prevention
August 20, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Job Trends
7 biopharma M&A deals where layoffs followed
August 20, 2026
·
5 min read
·
Angela Gabriel
Insights
Italian biotech gains momentum as VC funding, tech transfer environment improve
August 17, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Regulatory
Pressure piles on Amgen after EU pulls Tavneos, flags ‘serious breaches’ in pivotal study
August 14, 2026
·
2 min read
·
Tristan Manalac
